Complementary treatment and markers in inflammatory bowel diseases
| dc.contributor.author | Pagoldh, Maria | |
| dc.date.accessioned | 2014-01-31T07:24:38Z | |
| dc.date.available | 2014-01-31T07:24:38Z | |
| dc.date.issued | 2014-01-31 | |
| dc.description.abstract | Complementary Treatment and Markers in Inflammatory Bowel Diseases Maria Pagoldh Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden Aims: The aims of this thesis were to evaluate potential prognostic markers and addition of complementary treatments in inflammatory bowel diseases. Background: Inflammatory bowel diseases, the two main types of which are ulcerative colitis and Crohn’s disease, affect nearly 1% of the Scandinavian population and implies a risk of a chronic progressive, disabling disease. When considering treatment options, issues are: pre-dicting short and long-term prognosis, selecting optimal treatment options and providing ap-propriate care for complications of the conditions or treatments. Methods: Selected variables were investigated to determine their ability to predict colectomy in an early phase of a severe attack of ulcerative colitis in patients admitted to hospital. Hy-perbaric oxygen treatment was tested as a complementary treatment in acute severe ulcerative colitis. Addition of supplementary treatment with cereals was evaluated in patients with se-quelae after intestinal resections. Results and Conclusions: Analyses of stool frequency, faecal weight and complement factor 3c in plasma may contribute to an early prediction of the disease course in a severe attack of ulcerative colitis. Hyperbaric oxygen treatment as a complementary treatment in a severe at-tack of ulcerative colitis does not improve clinical outcome. Specially processed cereals, as well as non-processed cereals, can be safely used in patients with previous intestinal resec-tions. Intake of non-processed cereals may decrease faecal volume in these patients. Key words: inflammatory bowel diseases, ulcerative colitis, Crohn disease, predictor, com-plementary therapies, hyperbaric oxygen therapy ISBN: 978-91-628-8844-2 http://hdl.handle.net/2077/34071 Gothenburg 2014 | sv |
| dc.gup.defencedate | 2014-02-21 | |
| dc.gup.defenceplace | Fredagen den 21 februari 2014, kl 13.00, Aulan, Centralkliniken Sahlgrenska Universitetssjukhuset/Östra sjukhuset | sv |
| dc.gup.department | Institute of Medicine. Department of Molecular and Clinical Medicine | sv |
| dc.gup.dissdb-fakultet | SA | |
| dc.gup.mail | maria.pagoldh@vgregion.se | sv |
| dc.gup.origin | University of Gothenburg. Sahlgrenska Academy | sv |
| dc.identifier.isbn | 978-91-628-8845-9 | |
| dc.identifier.uri | http://hdl.handle.net/2077/34071 | |
| dc.language.iso | eng | sv |
| dc.relation.haspart | I. Pagoldh M et al. Faecal analysis and plasma complement factor 3c levels at admissionfor an acute attack of ulcerative colistis are predictive of the need for colectomy. Eur J Gastroenterol Hepatol. 2014 Jan 13. [Epub ahead of print] ::PMID::24418832 | sv |
| dc.relation.haspart | II. Pagoldh M et al. Hyperbaric oxygen therapy does not improve the effects of standardized treatment in a severe attack of ulcerative colitis: a prospective randomized study. Scand J Gastroenterol 2013;48(9):1033-1040. Epub Jul 23. ::doi::10.3109/00365521.2013.819443 | sv |
| dc.relation.haspart | III. Pagoldh M et al. Effects of a supplementary diet with specially processed cereals in patients with short bowel syndrome. Eur J Gastroenterol Hepatol 2008;20:(11)1085-1093. ::doi::10.1097/MEG.0b013e328303c00a | sv |
| dc.subject | inflammatory bowel diseases | sv |
| dc.subject | ulcerative colitis | sv |
| dc.subject | Crohn disease | sv |
| dc.subject | predictor | sv |
| dc.subject | complementary therapies | sv |
| dc.subject | hyperbaric oxygen therapy | sv |
| dc.title | Complementary treatment and markers in inflammatory bowel diseases | sv |
| dc.type | text | eng |
| dc.type.degree | Doctor of Philosophy (Medicine) | sv |
| dc.type.svep | Doctoral thesis | eng |
Files
Original bundle
1 - 3 of 3
No Thumbnail Available
- Name:
- gupea_2077_34071_1.pdf
- Size:
- 150 KB
- Format:
- Adobe Portable Document Format
- Description:
- Cover
No Thumbnail Available
- Name:
- gupea_2077_34071_2.pdf
- Size:
- 850.48 KB
- Format:
- Adobe Portable Document Format
- Description:
- Thesis frame
No Thumbnail Available
- Name:
- gupea_2077_34071_3.pdf
- Size:
- 120.17 KB
- Format:
- Adobe Portable Document Format
- Description:
- Abstract
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 4.68 KB
- Format:
- Item-specific license agreed upon to submission
- Description: